CREATION.co

COPD Tracker: Data-loving HCPs continue to be active on X

18.09.2024 | Tracker

COPD Tracker: Data-loving HCPs continue to be active on X

In the month of August 2024, CREATION.co analysed 170 posts on X by 128 US healthcare professionals (HCPs) discussing chronic obstructive pulmonary disease (COPD). In these posts, HCPs educated each other on diagnosis and treatment, shared the latest research, and discussed emerging treatments.

HCPs educate and connect with peers 

As seen in previous months, HCPs in the COPD space use X to connect with and educate their peers. For example, in a post shared by 4 fellow HCPs, neurologist Lyell Jones posted an educational thread focusing on fatigue in a woman suffering with COPD. The post which kicked off the thread received 21,420 impressions and garnered interactions from HCPs around the world, not just the US.

Thought-starter: Many US HCPs use social media to stay up-to-date in COPD as it is a quick way of learning of new guidelines, approvals, clinical trials and other medical education knowledge. With this in mind, how can you best support and add value to your HCPs so they can keep up with the fast evolving COPD space? 

HCPs discussed emerging treatments

Medications continued to be the largest therapy type discussed by HCPs. Notably, two HCPs shared the results of the BICS trial, which found that treatment with bisoprolol did not reduce the number of self-reported COPD exacerbations requiring treatment.

Palliative care remained the second most discussed treatment type both in August and in the six months prior overall. Significantly, one post from the BMJ Thorax journal which shared the guidelines for palliative care referral criteria was shared three times by US HCPs on X, garnering 1,331 impressions. These guidelines gathered insight from “international experts” into the best way to identify the criteria for admitting COPD outpatients into specialist palliative care.

Thought-starter: Clinical guidelines are constantly evolving, and it is hard for clinicians to stay abreast of them. How can you support your HCPs in keeping up with the guidelines?

Emphysema on the public stage

One breaking story which got HCPs talking on X was the revelation that American filmmaker David Lynch had contracted emphysema. Lynch’s love for smoking was well documented, but has since changed his lifestyle to cope with the illness. US HCPs posted 15 times over three days about this event.

In the interview which broke the news to the public, it is stated Lynch “fears he will get Covid” since he will be at-risk due to his illness. As such three HCPs shared this post, encouraging the public to continue wearing masks to protect the “millions” of vulnerable individuals like Lynch.

Most impactful HCPs discussing COPD on X in August 2024

Using CREATION.co’s unique impact score which scores HCPs based on metrics like engagement by HCP peers, social media metrics and number of COPD posts for that month, we identified the most impactful HCPs in the US discussing COPD in August 2024. This month, the three most impactful HCPs in August all had a focus on research and data.

The most impactful US HCP talking about COPD in August was physician scientist Naftali Kaminski, who educated peers. He shared recent COPD research by peers, celebrating the work of a fellow impactful HCP, Melanie Königshoff. Kaminski posted nine times, the most of all US HCPs in the month of August.

The next most impactful author this month was the aforementioned Melanie Königshoff. As stated, the research group she is a part of had a paper published this month, so her six posts were mostly raising awareness of the work, and resharing positive comments about it. This work presented research into stem cell function in COPD.

Third most impactful was Kent Willis, a paediatrician working at the University of Alabama at Birmingham. In August, he posted four times, predominantly sharing research from his lab about combatting lung inflammation in COPD and BPD (bronchopulmonary dysplasia).

Each month, we track online HCP conversations on COPD. If this interests you, you can check out our Respiratory Trackers, or dive into one of our HCP Insight Trackers focused on Product Approvals or Top 50 Pharmaceutical companies. 

Receive updates straight to your inbox by signing up for our monthly eJournal CREATION Knowledge.

 

 

 

 

 

Share this article

Meet the Author

Ben Stott

Ben, a recent physics graduate, brings a strong foundation in analytical and technical skills honed during his academic journey. Armed with this knowledge, he uncovers valuable data insights to present to the pharmaceutical industry.

In his spare time, Ben loves to play hockey and spend time with friends and family. You’ll often catch him watching sport, or attempting a new geography quiz.

Suggested next

22.07.2021 | Article

UK HCPs debate the impact of “Freedom Day”

UK HCPs debate the impact of “Freedom Day”

By Mark Sullivan

17.11.2020 | Article

UK HCPs praise efficacy of Pfizer’s COVID-19 vaccine but have concerns about practicality

Pfizer and BioNTech announce collaboration and vaccine efficacy

By Laura Marsh

View all articles >